TIAA CREF INVESTMENT MANAGEMENT LLC - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 146 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.38 and the average weighting 0.8%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$473,000
-48.1%
85,036
-38.1%
0.00%
-100.0%
Q4 2018$911,000
-73.9%
137,267
-58.0%
0.00%0.0%
Q3 2018$3,486,000
+115.2%
326,734
+142.0%
0.00%0.0%
Q2 2018$1,620,000
+88.4%
135,012
+34.5%
0.00%0.0%
Q1 2018$860,000
-13.3%
100,3760.0%0.00%0.0%
Q4 2017$992,000
-30.7%
100,376
-13.8%
0.00%0.0%
Q3 2017$1,431,000
-24.6%
116,401
+0.9%
0.00%0.0%
Q2 2017$1,898,000
-14.0%
115,360
-25.1%
0.00%
-50.0%
Q1 2017$2,208,000
-28.9%
153,983
-31.5%
0.00%0.0%
Q4 2016$3,107,000
-41.6%
224,648
-23.7%
0.00%
-33.3%
Q3 2016$5,323,000
+74.6%
294,598
+38.7%
0.00%
+50.0%
Q2 2016$3,048,000
+66.9%
212,427
+39.0%
0.00%
+100.0%
Q1 2016$1,826,000
-15.7%
152,774
-6.2%
0.00%
-50.0%
Q4 2015$2,167,000
+7.4%
162,804
-13.3%
0.00%0.0%
Q3 2015$2,017,000
+76.8%
187,788
+32.4%
0.00%
+100.0%
Q2 2015$1,141,000141,7920.00%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$34,786,00099.98%
Artal Group S.A. 57,517,978$463,019,00019.93%
MASTERS CAPITAL MANAGEMENT LLC 1,129,708$9,094,0000.30%
Rhenman & Partners Asset Management AB 170,915$1,376,0000.16%
Round Table Services, LLC 21,611$174,0000.14%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$287,0000.10%
FALCON POINT CAPITAL, LLC 37,039$298,0000.10%
SABBY MANAGEMENT, LLC 318,775$2,566,0000.09%
WILLIAM HARRIS INVESTORS INC 39,495$318,0000.09%
HOWARD HUGHES MEDICAL INSTITUTE 51,520$415,0000.09%
View complete list of LEXICON PHARMACEUTICALS INC shareholders